[Problems in the use of newly introduced anti-shock agents].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000818:Animals; D001550:Benzamidines; D003169:Complement Inactivator Proteins / Q000627:therapeutic use; D016670:Gabexate; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D051379:Mice; D051381:Rats; D012769:Shock / Q000188:drug therapy*; D012772:Shock, Septic / Q000188:drug therapy
D000305:Adrenal Cortex Hormones; D001550:Benzamidines; D003169:Complement Inactivator Proteins; D006146:Guanidines; D016670:Gabexate; C032855:nafamostat